XML 21 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Cash Flows From Operating Activities:              
Net loss $ (3,679,043) $ (5,979,579) $ (1,919,071) $ (6,698,242) $ (17,979,171) $ (9,299,498)  
Adjustments to reconcile net loss to net cash flows used in operating activities:              
Depreciation and amortization         1,656,627 1,646,207  
Stock-based compensation         378,917 1,028,084  
Non-cash interest expense         576,380  
Change in fair value of warrant derivative liabilities (1,863,326)   (1,164,849)   (1,803,560) (6,726,638)  
Gain on extinguishment of liabilities (507,304)     (507,304)  
Gain on extinguishment of warrant derivative liabilities         (3,624,794)  
Convertible debt discount amortization         1,887,273  
Loss on conversion of debt     93,386  
Provision for inventory obsolescence         (918,571) 143,664  
Provision for doubtful accounts receivable         47,931 (161,239)  
Allowance for doubtful lease reserve         5,000  
Change in fair value of contingent consideration promissory note         (177,909) (347,169)  
(Increase) decrease in:              
Accounts receivable – trade         (26,605) 143,937  
Accounts receivable – other         1,453,710 (3,426,732)  
Inventories         2,563,198 (1,448,044)  
Prepaid expenses         1,142,798 531,508  
Operating lease right of use assets         285,667 306,783  
Other assets         (1,477,391) (4,125,776)  
Increase (decrease) in:              
Accounts payable         3,619,557 5,133,934  
Accrued expenses         1,717,101 (106,800)  
Income taxes payable         (17,544) 9,969  
Lease deposit         10,445  
Operating lease obligations         (285,667) (306,782)  
Contract liabilities         1,913,574 2,831,394  
Net cash used in operating activities         (5,842,158) (17,797,992)  
Cash Flows from Investing Activities:              
Purchases of property, plant and equipment         (86,348) (1,947,127)  
Additions to intangible assets         (110,893) (158,218)  
Cash paid for acquisition of Medical Billing Company         (1,153,627)  
Cash paid for asset acquisition of Medical Billing Company         (230,000)  
Net cash used in investing activities         (197,241) (3,488,972)  
Cash Flows from Financing Activities:              
Repurchase and cancellation of common stock         (4,026,523)  
Distribution to noncontrolling interest in consolidated subsidiary         (15,692)  
Net proceeds of convertible debt with detachable warrants         2,640,000  
Net proceeds of related party note payable         2,325,000  
Proceeds – Commercial Extension of Credit – Entertainment Segment         1,224,577  
Payments on Commercial Extension of Credit – Entertainment Segment         (1,156,441)  
Principal payment on contingent consideration promissory notes         (318,105) (383,222)  
Net cash (used in) provided by financing activities         4,715,031 (4,425,437)  
Net decrease in cash and cash equivalents         (1,324,368) (25,712,401)  
Cash, cash equivalents, beginning of period   $ 3,532,199   $ 32,007,792 3,532,199 32,007,792 $ 32,007,792
Cash, cash equivalents, end of period $ 2,207,831   6,295,391   2,207,831 6,295,391 $ 3,532,199
Supplemental disclosures of cash flow information:              
Cash payments for interest         26,220 44,783  
Cash payments for income taxes         9,447 9,969  
Supplemental disclosures of non-cash investing and financing activities:              
ROU and lease liability recorded on extension of lease         538,056  
Conversion of convertible notes payable into common stock         119,750  
Issuance of common stock through warrant exchange agreement     $ 4,495,500   4,495,500  
Issuance of contingent consideration promissory note for business acquired         855,000  
Assets acquired in business acquisitions         190,631  
Liabilities assumed in the business acquisition         387,005  
Goodwill acquired in business acquisitions         2,100,000  
Restricted common stock grant         35 715  
Reverse stock split rounding issuances         24  
Restricted common stock forfeitures         4 65  
Debt discount on convertible note         $ 3,000,000